Breaking News Instant updates and real-time market news.

ECYT

Endocyte

$4.96

0.14 (2.90%)

, PGNX

Progenics

$5.52

-0.07 (-1.25%)

13:25
11/27/17
11/27
13:25
11/27/17
13:25

Wedbush biotech analyst holds an analyst/industry conference call

Biotech Analyst Nierengarten, along with Key Opinion Leader Michael Morris, MD and Medical Oncologist at Memorial Sloan Kettering, provide an update on radiopharmaceutical oncology on an Analyst/Industry conference call to be held on November 27 at 2 pm.

ECYT

Endocyte

$4.96

0.14 (2.90%)

PGNX

Progenics

$5.52

-0.07 (-1.25%)

  • 27

    Nov

ECYT Endocyte
$4.96

0.14 (2.90%)

10/03/17
WEDB
10/03/17
UPGRADE
WEDB
Outperform
Endocyte upgraded to Outperform from Neutral at Wedbush
Wedbush analyst David Nierengarten upgraded Endocyte to Buy and increased its price target to $7 from $2 based on the attractive PSMA-617 opportunity and cheap valuation, despite share strength yesterday. The analyst sees potential peak sales of $1B and said it could have a broader opportunity and fewer hurdles in scaling up relative to Xofigo.
06/05/17
06/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Andy Hargreaves saying upside from the launch of iPhone 8 is already reflected in the shares. An "extremely strong iPhone 8 cycle" is being priced into the stock while little weight is being given to gross margins, supply issues, or the likelihood for declines beyond the iPhone 8, Hargreaves tells investors in a research note. 2. Perrigo (PRGO) downgraded to Underperform from Sector Perform at RBC Capital with analyst Randall Stanicky saying the growth rate of the company's U.S. consumer business "has structurally re-rated lower" amid pricing headwinds and share losses. 3. Endocyte (ECYT) downgraded to Neutral from Outperform at Wedbush and to Market Perform from Outperform at Cowen. 4. Affiliated Managers (AMG) was downgraded to Neutral from Buy at Citi while Federated Investors (FII) was downgraded to Sell from Neutral. 5. Veeva (VEEV) downgraded to Equal Weight from Overweight at Morgan Stanley with the firm's analyst saying the 60%+ move in shares year-to-date captures much of the near-term upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/05/17
WEDB
06/05/17
DOWNGRADE
WEDB
Neutral
Endocyte downgraded on clinical data, pipeline changes at Wedbush
As noted earlier, Wedbush downgraded Endocyte to Neutral from Outperform. Analyst David Nierengarten downgraded the stock after the company reported that the level of activity observed in trials did not support further development of its EC1456 or its EC1169 in taxane-naive CRPC. The company will only develop EC1169 in the taxanes-exposed CRPC population going forward and will discontinue EC1456, the analyst reported. He removed all sales from both drugs from his model ,citing uncertain initial results of 1169 in the taxane-exposed population. Target to $2 from $8.
06/05/17
COWN
06/05/17
DOWNGRADE
COWN
Market Perform
Endocyte downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Boris Peaker downgraded Endocyte to Market Perform from Outperform due to the failure of its lead asset, EC1456, and higher uncertainty with its pipeline.
PGNX Progenics
$5.52

-0.07 (-1.25%)

07/12/17
CANT
07/12/17
INITIATION
Target $15
CANT
Overweight
Progenics initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Mara Goldstein started Progenics Pharmaceuticals with an Overweight rating and $15 price target. The analyst views the expectations of both the company's clinical and commercial success as modest.
04/24/17
NEED
04/24/17
NO CHANGE
Target $14
NEED
Strong Buy
Needham remains a buyer of Progenics after recent pullback
Needham analyst Chad Messer notes that Progenics' shares have pulled back since the reporting of controversial pivotal Azedra data a few weeks ago, but he is quite optimistic about Azedra's chances for approval and commercial success. The analyst says he remains a buyer of Progenics, reiterating a Strong Buy rating and $14 price target on the shares.
02/06/17
02/06/17
UPGRADE
Target $14

Strong Buy
Progenics upgraded to Strong Buy at Needham
As previously reported, Needham analyst Chad Messer upgraded Progenics to Strong Buy from Buy ahead of pivotal Azdedra data, and potential late 2017 launch. The analyst continues to expect "significant appreciation" in shares this year as the company launches its first wholly owned product and moves rapidly toward profitability. He also raised his price target on the shares to $14 from $11.
02/06/17
NEED
02/06/17
UPGRADE
NEED
Strong Buy
Progenics upgraded to Strong Buy from Buy at Needham

TODAY'S FREE FLY STORIES

STLD

Steel Dynamics

$39.85

0.01 (0.03%)

18:07
12/15/17
12/15
18:07
12/15/17
18:07
Earnings
Steel Dynamics sees Q4 EPS 48c-52c, consensus 55c »

"Despite a lower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$266.51

2.21 (0.84%)

, SPX

S&P 500

17:42
12/15/17
12/15
17:42
12/15/17
17:42
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

House plans to vote…

SPY

SPDR S&P 500 ETF Trust

$266.51

2.21 (0.84%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$266.51

2.21 (0.84%)

, SPX

S&P 500

17:42
12/15/17
12/15
17:42
12/15/17
17:42
Periodicals
Republicans release final tax bill proposal, CNBC reports »

Republicans have released…

SPY

SPDR S&P 500 ETF Trust

$266.51

2.21 (0.84%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$162.60

5.4 (3.44%)

17:37
12/15/17
12/15
17:37
12/15/17
17:37
Hot Stocks
McKesson awarded $400M government contract »

McKesson has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEE

Ameren

$60.94

0.11 (0.18%)

17:34
12/15/17
12/15
17:34
12/15/17
17:34
Syndicate
Breaking Syndicate news story on Ameren »

Ameren files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKAM

Akamai

$57.76

1 (1.76%)

, AMTD

TD Ameritrade

$51.98

1.1 (2.16%)

17:33
12/15/17
12/15
17:33
12/15/17
17:33
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Akamai (AKAM), up…

AKAM

Akamai

$57.76

1 (1.76%)

AMTD

TD Ameritrade

$51.98

1.1 (2.16%)

PG

Procter & Gamble

$91.89

0.89 (0.98%)

PETX

Aratana Therapeutics

$5.73

0.15 (2.69%)

HPE

HP Enterprise

$14.41

0.17 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 13

    Dec

GRMN

Garmin

$58.36

-1.1 (-1.85%)

17:32
12/15/17
12/15
17:32
12/15/17
17:32
Recommendations
Garmin analyst commentary at Tigress Financial »

Garmin growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$322.82

5.81 (1.83%)

17:26
12/15/17
12/15
17:26
12/15/17
17:26
Hot Stocks
Lockheed Martin awarded $135.83M government contract »

Lockheed Martin is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

PG

Procter & Gamble

$91.89

0.89 (0.98%)

17:19
12/15/17
12/15
17:19
12/15/17
17:19
Hot Stocks
Peltz to join Procter & Gamble board effective March 1, 2018 »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$91.89

0.89 (0.98%)

, NVS

Novartis

$84.86

0.39 (0.46%)

17:19
12/15/17
12/15
17:19
12/15/17
17:19
Hot Stocks
P&G names Trian's Nelson Peltz, Novartis CEO Jimenez to board »

Procter & Gamble (PG)…

PG

Procter & Gamble

$91.89

0.89 (0.98%)

NVS

Novartis

$84.86

0.39 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 17

    May

SNSS

Sunesis

$3.36

0.16 (5.00%)

17:16
12/15/17
12/15
17:16
12/15/17
17:16
Hot Stocks
Sunesis CEO Swisher to resign, Dayton Misfeldt named interim CEO »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.24

0.5 (1.32%)

, BA

Boeing

$293.94

0.06 (0.02%)

17:09
12/15/17
12/15
17:09
12/15/17
17:09
Hot Stocks
AT&T CEO Stephenson resigns from Boeing board »

According to a regulatory…

T

AT&T

$38.24

0.5 (1.32%)

BA

Boeing

$293.94

0.06 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

HPE

HP Enterprise

$14.41

0.17 (1.19%)

17:03
12/15/17
12/15
17:03
12/15/17
17:03
Syndicate
Breaking Syndicate news story on HP Enterprise »

HP Enterprise files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

FSV

FirstService

$67.87

-0.54 (-0.79%)

17:02
12/15/17
12/15
17:02
12/15/17
17:02
Hot Stocks
Breaking Hot Stocks news story on FirstService »

Jay S. Hennick reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETP

Energy Transfer Partners

$17.50

0.08 (0.46%)

17:01
12/15/17
12/15
17:01
12/15/17
17:01
Hot Stocks
Energy Transfer gets FERC approval to place Rover Pipeline's 1B into service »

Energy Transfer Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$51.98

1.1 (2.16%)

, BTC

Bitcoin

16:56
12/15/17
12/15
16:56
12/15/17
16:56
Periodicals
TD Ameritrade to offer bitcoin futures, CNBC reports »

TD Ameritrade will now…

AMTD

TD Ameritrade

$51.98

1.1 (2.16%)

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HIIQ

Health Insurance Innovations

$26.90

-0.65 (-2.36%)

16:55
12/15/17
12/15
16:55
12/15/17
16:55
Hot Stocks
Breaking Hot Stocks news story on Health Insurance Innovations »

Cannell Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$24.96

0.13 (0.52%)

16:51
12/15/17
12/15
16:51
12/15/17
16:51
Hot Stocks
Breaking Hot Stocks news story on Regional Management »

Basswood Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBY

NovaBay

$3.35

-0.0668 (-1.96%)

16:50
12/15/17
12/15
16:50
12/15/17
16:50
Syndicate
NovaBay files to sell $12M of common stock »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.24

0.5 (1.32%)

, TWX

Time Warner

$90.25

0.6 (0.67%)

16:50
12/15/17
12/15
16:50
12/15/17
16:50
Periodicals
DOJ, AT&T held unsuccessful settlement talks, Reuters reports »

The U.S. Department of…

T

AT&T

$38.24

0.5 (1.32%)

TWX

Time Warner

$90.25

0.6 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$6.06

0.2 (3.41%)

16:48
12/15/17
12/15
16:48
12/15/17
16:48
Syndicate
Breaking Syndicate news story on Sunrun »

Sunrun files to sell 30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUN

Sunrun

$6.06

0.2 (3.41%)

16:47
12/15/17
12/15
16:47
12/15/17
16:47
Syndicate
Breaking Syndicate news story on Sunrun »

Sunrun files $328.7M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SINO

Sino-Global

$2.59

0.05 (1.97%)

16:43
12/15/17
12/15
16:43
12/15/17
16:43
Syndicate
Breaking Syndicate news story on Sino-Global »

Sino-Global files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALN

American Lorain

16:35
12/15/17
12/15
16:35
12/15/17
16:35
Hot Stocks
American Lorain regains compliance for continued listing on NYSE »

American Lorain announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$60.02

0.55 (0.92%)

16:32
12/15/17
12/15
16:32
12/15/17
16:32
Hot Stocks
Black Hills Arkansas subsidiary requests rate review for system investments »

Black Hills Corp.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.